238 related articles for article (PubMed ID: 12352668)
1. Familial head and neck cancer: molecular analysis of a new clinical entity.
Yu KK; Zanation AM; Moss JR; Yarbrough WG
Laryngoscope; 2002 Sep; 112(9):1587-93. PubMed ID: 12352668
[TBL] [Abstract][Full Text] [Related]
2. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
Yarbrough WG
Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329
[TBL] [Abstract][Full Text] [Related]
3. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
4. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.
Bahuau M; Vidaud D; Jenkins RB; Bièche I; Kimmel DW; Assouline B; Smith JS; Alderete B; Cayuela JM; Harpey JP; Caille B; Vidaud M
Cancer Res; 1998 Jun; 58(11):2298-303. PubMed ID: 9622062
[TBL] [Abstract][Full Text] [Related]
5. Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma.
Liu L; Lassam NJ; Slingerland JM; Bailey D; Cole D; Jenkins R; Hogg D
Oncogene; 1995 Jul; 11(2):405-12. PubMed ID: 7624155
[TBL] [Abstract][Full Text] [Related]
6. p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro.
Liggett WH; Sewell DA; Rocco J; Ahrendt SA; Koch W; Sidransky D
Cancer Res; 1996 Sep; 56(18):4119-23. PubMed ID: 8797577
[TBL] [Abstract][Full Text] [Related]
7. [Biallelic inactivation of the p16-Gen in a metachronous triple carcinoma in the oropharyngeal region].
Motsch C; Giers A; Boltze C; Evert M; Freigang B; Roessner A; Schneider-Stock R
Laryngorhinootologie; 2004 Jan; 83(1):55-60. PubMed ID: 14740307
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
9. Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers.
Grüttgen A; Reichenzeller M; Jünger M; Schlien S; Affolter A; Bosch FX
J Pathol; 2001 Jul; 194(3):311-7. PubMed ID: 11439363
[TBL] [Abstract][Full Text] [Related]
10. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma.
Reed AL; Califano J; Cairns P; Westra WH; Jones RM; Koch W; Ahrendt S; Eby Y; Sewell D; Nawroz H; Bartek J; Sidransky D
Cancer Res; 1996 Aug; 56(16):3630-3. PubMed ID: 8705996
[TBL] [Abstract][Full Text] [Related]
11. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
[TBL] [Abstract][Full Text] [Related]
12. Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families.
Yakobson E; Shemesh P; Azizi E; Winkler E; Lassam N; Hogg D; Brookes S; Peters G; Lotem M; Zlotogorski A; Landau M; Safro M; Shafir R; Friedman E; Peretz H
Eur J Hum Genet; 2000 Aug; 8(8):590-6. PubMed ID: 10951521
[TBL] [Abstract][Full Text] [Related]
13. Head and neck squamous cell carcinoma in FAMMM syndrome.
Vinarsky V; Fine RL; Assaad A; Qian Y; Chabot JA; Su GH; Frucht H
Head Neck; 2009 Nov; 31(11):1524-7. PubMed ID: 19360740
[TBL] [Abstract][Full Text] [Related]
14. Deletion of P15 (MTS2) in head and neck squamous cell carcinomas.
Roesler JM; Livingston EH; Srivatsan E; Chang P; Wang MB
J Surg Res; 1998 Jun; 77(1):50-4. PubMed ID: 9698532
[TBL] [Abstract][Full Text] [Related]
15. No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours.
Jefferies S; Edwards SM; Hamoudi RA; A'Hern R; Foulkes W; Goldgar D; Eeles R;
Br J Cancer; 2001 Nov; 85(9):1383-6. PubMed ID: 11720478
[TBL] [Abstract][Full Text] [Related]
16. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression.
Reed JA; Loganzo F; Shea CR; Walker GJ; Flores JF; Glendening JM; Bogdany JK; Shiel MJ; Haluska FG; Fountain JW
Cancer Res; 1995 Jul; 55(13):2713-8. PubMed ID: 7796391
[TBL] [Abstract][Full Text] [Related]
17. A melanoma-associated germline mutation in exon 1beta inactivates p14ARF.
Rizos H; Puig S; Badenas C; Malvehy J; Darmanian AP; Jiménez L; Milà M; Kefford RF
Oncogene; 2001 Sep; 20(39):5543-7. PubMed ID: 11571653
[TBL] [Abstract][Full Text] [Related]
18. Functional impairment of p16(INK4A) due to CDKN2A p.Gly23Asp missense mutation.
Scaini MC; Rossi E; de Siqueira Torres PL; Zullato D; Callegaro M; Casella C; Quaggio M; Agata S; Malacrida S; Chiarion-Sileni V; Vecchiato A; Alaibac M; Montagna M; Mann GJ; Menin C; D'Andrea E
Mutat Res; 2009 Dec; 671(1-2):26-32. PubMed ID: 19712690
[TBL] [Abstract][Full Text] [Related]
19. p16(INK4alpha)/exon 2 mutations in squamous cell carcinoma of the head and neck region.
Lehnerdt G; Fischer M
Acta Otolaryngol; 2006 Apr; 126(4):414-7. PubMed ID: 16608795
[TBL] [Abstract][Full Text] [Related]
20. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV.
Olshan AF; Weissler MC; Pei H; Conway K; Anderson S; Fried DB; Yarbrough WG
Oncogene; 1997 Feb; 14(7):811-8. PubMed ID: 9047388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]